ROL vs STIM · P/E 41, rev $3.39B vs rev $74.9M
Rollins Inc (ROL) versus Neuronetics Inc (STIM) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Neuronetics Inc (STIM) is a medical devices company listed on NASDAQ.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Latest reported STIM revenue for 2024-12-31 was $74.9M. Net income was -$43.7M. Revenue was up 5.0% from 2023-12-31 to 2024-12-31. STIM currently screens at market cap $84.2M.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. STIM currently screens at market cap $84.2M.
Not investment advice. Open the ROL and STIM stock pages for the full models.
Not investment advice.